<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Metabolomics":2,
"biomarker discovery":1,
"lipidomics":1,
"thyroid cancer":20,
"papillary thyroid cancer":7,
"single nucleotide polymorphism":1,
"vascular endothelial growth factor":1,
"Disease progression":1,
"Next-generation sequencing":1,
"RNA-Seq":1,
"TENM1":1,
"DICER":1,
"Iodine metabolism-related genes":1,
"MicroRNA":2,
"Thyroid":16,
"Thyroid cell differentiation":1,
"Thyroid tumor":2,
"Alternative chemical":1,
"Cell line":1,
"Endocrine disruption":1,
"Substitute":1,
"Thyroid hormone":1,
"Breast cancer":4,
"Disease-free survival":1,
"Family history of other cancer":1,
"Prognosis":3,
"Contrast-enhanced ultrasound":1,
"elastography":2,
"papillary thyroid microcarcinoma":1,
"subcentimeter nodule":1,
"ultrasound":7,
"EMT":1,
"Endocrine cancers":1,
"Invasion":3,
"Metastasis":5,
"Small RNA":1,
"Camptothecin":1,
"anaplastic thyroid carcinoma":1,
"cell adhesion":1,
"cell migration":1,
"β-cyclodextrin-nanosponges":1,
"Galectin-3":1,
"MMP-2":1,
"MMP-9":1,
"Runx2":1,
"THYROID CARCINOMA":7,
"cancer/malignancy/neoplasia: risk factors":1,
"clinical research/practice":1,
"epidemiology":2,
"immunosuppression/immune modulation":1,
"kidney transplantation/nephrology":1,
"organ transplantation in general":1,
"translational research/science":1,
"papillary thyroid carcinoma":15,
"thyroglobulin":4,
"transaxillary":1,
"FGFR1":1,
"PKM2":2,
"RACK1":1,
"cell growth and migration":1,
"lung cancer":1,
"I131":1,
"adverse events":1,
"pediatric differentiated thyroid cancer":1,
"radioiodine":3,
"ATP4A":1,
"Gastric neuroendocrine tumor":1,
"Hypothyroidism":4,
"PTH1R":1,
"Rheumatoid arthritis":1,
"Leukocytes":2,
"platelets":1,
"white blood cells":1,
"Differentiated thyroid cancer":2,
"Tg-Ab":1,
"follow-up":2,
"thyroglobulin-antibodies":1,
"lymph nodes":2,
"neck recurrence":1,
"outcomes":1,
"survival":1,
"Aggressive variant of papillary thyroid cancer":1,
"Classical papillary thyroid carcinoma":1,
"Diffuse sclerosing variant":1,
"Ongoing risk stratification":2,
"Tall cell variant":1,
"Ablación":1,
"Ablation":1,
"Cost-effectiveness":1,
"Coste-efectividad":1,
"Cáncer de tiroides":1,
"Hipotiroidismo":1,
"rhTSH":1,
"adult thyroid":1,
"clinical":1,
"general":1,
"head and neck ultrasound":1,
"radiation treatment":1,
"radiology":1,
"surgery":3,
"Cell proliferation":1,
"Follicular thyroid cancer":1,
"MAPK/Erk":1,
"Migration":2,
"PI3K/Akt":1,
"SOSTDC1":1,
"histotypes":1,
"idiopathic pulmonary fibrosis":1,
"immunohistochemistry":1,
"lung carcinoma":1,
"classification":1,
"thyroid carcinoma, nonmedullary":1,
"thyroid carcinoma, papillary":1,
"thyroid neoplasms":5,
"thyroid nodule":5,
"novel therapies":1,
"protein kinases":1,
"protein kinases inhibitors":1,
"thyroid cancer stem cells":1,
"thyroid carcinomas":1,
"chondrosarcoma":1,
"fine-needle aspiration":7,
"laryngeal":1,
"medullary carcinoma":1,
"DKI":1,
"DWI":1,
"VEGF":1,
"RAS mutation":1,
"adolescent":1,
"cancer":11,
"childhood":1,
"follicular thyroid carcinoma":2,
"paediatric":1,
"Head and neck cancer":1,
"Population-based study":1,
"Radiotherapy":1,
"18F-DOPA":1,
"18F-FDG":1,
"Medullary thyroid carcinoma":2,
"PET/CT":1,
"recurrence":2,
"Pregnancy":2,
"cancer survivor":1,
"maternal mortality":1,
"obstetric outcome":1,
"anaplastic thyroid cancer":2,
"mammalian target of rapamycin (mTOR) inhibition":1,
"sorafenib":2,
"v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutation":1,
"BRAF V600E":1,
"BRAF mutation":2,
"TERT promoter":1,
"meta-analysis":2,
"review":3,
"Bethesda II":1,
"False negative cytology":1,
"Malignancy":2,
"Solitary thyroid nodule":1,
"Thyroid nodule size":1,
"Hemithyroidectomy":1,
"Parathyroid gland":1,
"Thyroid surgery":1,
"Cardiovascular disease":2,
"Comorbidity":1,
"Trends":1,
"cohort":1,
"mortality":2,
"neoplasm":1,
"timing":1,
"68-Ga 177-Lu DOTA &amp":1,
"PSMA":1,
"FES":1,
"PET-CT":1,
"SPECT-CT":1,
"Tumor heterogeneity":1,
"functional imaging":1,
"molecular characterization of tumor":1,
"adequacy":1,
"biopsy":2,
"multiple nodules":1,
"Hydroxylated polybrominated diphenylethers (OH-PBDEs)":1,
"Polybrominated diphenylethers (PBDEs)":1,
"Serum":1,
"Thyroid function":1,
"Convolutional neural network":1,
"Segmentation":1,
"Ultrasound image":1,
"EGFR":1,
"Snx5":1,
"TSHR":1,
"endosomal trafficking":1,
"Pre-menopausal breast cancer":1,
"cost analysis":1,
"discrete choice experiments":1,
"endocrine therapy":1,
"long-acting formulation":1,
"practice guideline":1,
"ultrasonography":3,
"Antiangiogenic therapy":1,
"Glioblastoma":2,
"Lenvatinib":1,
"Magnetic resonance imaging":1,
"Receptor tyrosine kinase inhibitor":1,
"goiter":1,
"neck ultrasound":1,
"nodular goiter":1,
"thyroid gland":1,
"volume":1,
"Cervical lymph nodes":1,
"Contrast-enhanced ultrasonography":2,
"Metastatic":1,
"Prophylactic central neck dissection":1,
"cN0":1,
"adipofascial flap":1,
"external jugular vein":1,
"veno-accompanying artery":1,
"veno-accompanying artery adipofascial (VAF)":1,
"venoadipofascial flap":1,
"National Health Insurance Research Database":2,
"cohort study":1,
"radioiodine (I-131)":1,
"stroke":1,
"dynamic risk stratification":2,
"medullary thyroid cancer":5,
"recurrence risk":1,
"Ablative treatment":1,
"Dosimetry":1,
"Gamma spectrometry":1,
"Hyperthyroidism":1,
"Nuclear medicine":1,
"Radioactive iodine":1,
"cytomorphology":1,
"diagnosis":3,
"fine-needle aspiration (FNA)":1,
"follicular variant of papillary thyroid carcinoma (FVPTC)":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":3,
"Fine needle aspiration and biopsy":1,
"Nodules":1,
"MAPK":2,
"PI3K":1,
"signaling":1,
"Neck mass":1,
"bone":1,
"calcification":1,
"hard":1,
"Horner's syndrome":1,
"Squamous cell carcinoma":1,
"Superior cervical ganglion":1,
"45 years":1,
"classical papillary thyroid cancer":1,
"stage I":1,
"Microwave ablation":1,
"Thermal ablation":1,
"Thyroid nodules":5,
"Ultrasound-guided":1,
"MAPK pathway":1,
"Sorafenib, Forskolin":1,
"Well-differentiated thyroid cancer":1,
"cAMP pathway":1,
"MiR-338":1,
"epigenetic modification":1,
"β-catenin":1,
"NIFTP":1,
"diagnostic value":2,
"molecular markers":1,
"YAP1":1,
"miR-375":2,
"AUS/FLUS":1,
"FN/suspicious for FN":1,
"Lateral neck metastasis":1,
"MRI":1,
"Neck dissection":1,
"Negative predictive value":1,
"DTC":1,
"anxiety":1,
"interview":1,
"qualitative":1,
"quality of life":1,
"Endobronchial ultrasound-guided transbronchial needle aspiration":1,
"mediastinal ectopic thyroid carcinoma":1,
"mediastinal lesion":1,
"Aspirin":1,
"Clinical research":1,
"Molecular mechanisms":1,
"Cell growth":1,
"Cell invasion":1,
"PVT1":1,
"SOX2":1,
"Transcription factor":1,
"AKT":1,
"Bisphenol A":1,
"Estrogen receptor":1,
"mTOR":1,
"Calcitonin":2,
"Fine-needle aspiration cytology":3,
"Immunocytochemical staining":1,
"Needle wash-out fluid":1,
"chemokine":1,
"inflammation":1,
"AJCC/UICC staging system":1,
"Epidemiology and End Results":1,
"National Cancer Database":1,
"Surveillance":1,
"disease-specific survival":1,
"overall survival":2,
"The Bethesda System for Reporting Thyroid Cytopathology":1,
"MALAT1":1,
"Triple-negative breast cancer":1,
"lncRNA":1,
"miR-129-5p":1,
"Craniopharyngioma":2,
"Diabetes insipidus":1,
"Pituitary stalk sectioning":1,
"Postoperative recovery":1,
"KLF4":1,
"cancer stem cell":1,
"chemoresistance":1,
"antineoplastic agents":1,
"lanreotide":1,
"neuroendocrine carcinoma":1,
"somatostatin":1,
"carcinogenesis":1,
"iodothyronine deiodinases":1,
"neoplasia":1,
"thyroid hormone receptors":1,
"thyroid hormones":1,
"metabolism":1,
"mouse models":1,
"stem cells":1,
"succinate dehydrogenase":1,
"Berberine":1,
"Cell cycle arrest":1,
"Mitochondrial apoptosis":1,
"PI3K-AKT":1,
"dedifferentiation":1,
"hNIS":1,
"radioiodide resistance":1,
"tumor microenvironment":1,
"ABCG2":1,
"ALDHA1":1,
"breast cancer stem cell-like cells":1,
"doxorubicin":1,
"microbubble":1,
"RDM1":1,
"lentivirus":1,
"siRNA":1,
"radioiodide sialadenitis":1,
"sialadenitis":1,
"sialendoscopy":1,
"C-cell":1,
"RET mutation":1,
"minute medullary thyroid carcinoma":1,
"solid cell nests":1,
"antiviral treatment":1,
"cardiac and pulmonary manifestations":1,
"chronic hepatitis C virus":1,
"extrahepatic manifestations":1,
"mixed cryoglobulinemia":1,
"pathogenesis":1,
"Apolipoprotein":1,
"Cholesterol efflux":1,
"Lipid":1,
"Paraoxonase-1 activity":1,
"AKT3":1,
"Proliferation":2,
"miR-217":1,
"Common deletion":1,
"FNA cytology":1,
"Hurthle":1,
"Infarction":1,
"Mitochondrial DNA":1,
"donors and donation":1,
"patient referral":1,
"cytology":1,
"malignancy rates":1,
"nodule":1,
"Hepatocellular carcinoma":1,
"Liver transplantation":1,
"Second primary cancer":1,
"South Korea":1,
"Overdiagnosis":1,
"Screening":1,
"Bethesda":3,
"Fine needle aspiration cytology":1,
"Korea":1,
"In silico":1,
"Targets":1,
"RET M918T":1,
"cabozantinib":1,
"progression-free survival":1,
"Childhood cancer survivor":1,
"Disfunción gonadal":1,
"Endocrine sequelae":1,
"Gonadal dysfunction":1,
"Hipopituitarismo":1,
"Hypopituitarism":1,
"Secuelas endocrinas":1,
"Superviviente cáncer infantil":1,
"Incidental cancer":1,
"Incidental thyroid nodule":1,
"biomarkers":1,
"mass spectrometry":1,
"proteomics":1,
"cytopathology":2,
"follicular neoplasm":1,
"molecular testing":2,
"terminology":2,
"Calycosin":1,
"GPR30":1,
"Long non-coding RNA":1,
"WDR7-7":1,
"end-stage renal disease":1,
"thyroid abnormalities":1,
"waiting list for renal transplant":1,
"immunotherapy":1,
"nivolumab":1,
"fine needle aspiration":1,
"lymph node metastasis":1,
"mean intensity ratio of intratumoral/peripheral thyroid parenchyma":1,
"microvascular density":1,
"Wnt member 5a":1,
"tumor":1,
"tyrosine kinase-like orphan receptor 2":1,
"2017":1,
"Adult":1,
"Back pain":1,
"Dyspnoea":1,
"Error in diagnosis/pitfalls and caveats":1,
"Female":1,
"Fine needle aspiration biopsy":1,
"Histopathology":1,
"Male":1,
"November":1,
"Oncology":1,
"Thyroid ultrasonography":1,
"Thyroidectomy":2,
"Turkey":1,
"White":1,
"Radioiodine refractory papillary thyroid carcinoma":1,
"Thyroid stimulating hormone":1,
"Graves’ disease (GD)":1,
"Marine-Lenhart syndrome":1,
"children and adolescents":1,
"hot nodule":1,
"BRAF":1,
"False-negative rate":1,
"AGREE instrument":1,
"consensus":1,
"guideline":1,
"quality of guidance document":1,
"surgical management":1,
"FYN":1,
"tumorigenesis":1,
"Carcinoma, papillary":1,
"Receiver operating characteristic curve":1,
"Ribosomal proteins":1,
"Epigenetics":1,
"Gene mutation":1,
"Recombinant human growth hormone":1,
"Treatment outcome":1,
"China":1,
"Incidence":1,
"Esophageal carcinoma":1,
"Gastrointestinal stromal tumors":1,
"Non-small cell lung cancer":1,
"Thyroid papillary carcinoma":1,
"multi-organ primary carcinoma":1,
"folate":1,
"folic acid":1,
"neural tube defects":1,
"safety":1,
"Thailand":1,
"The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)":1,
"Thyroid fine-needle aspiration":1,
"Autism spectrum disorder":1,
"Lung metastases":1,
"Pediatrics":1,
"antioxidant properties":1,
"nitroxide":1,
"nitroxide as drugs":1,
"oxidative stress":1,
"spin labelled drug analogues":1,
"Multinodular goitre":1,
"Saudi Arabia":1,
"Solitary nodule":1,
"Thyroid fine needle aspiration cytology":1,
"Polymorphism":1,
"Predisposition":1,
"Silicones":1,
"Surgical instruments":1,
"Surgical wound":1,
"Gamma-probe":1,
"Phytate":1,
"Sentinel lymph node biopsy":1,
"Single-photon emission-computed tomography":1,
"CD44+/CD24−":1,
"cell proliferation and chemoresistance":1,
"p63":1,
"Laser ablation":1,
"Minimally invasive therapies":1,
"Radiofrequency ablation":1,
"Positron-emission tomography":1,
"Prostate cancer":1,
"Differentiated thyroid carcinoma":1,
"Papillary carcinoma":1,
"TNM staging":1,
"Ataxia-telangiectasia mutated gene-encoded protein":1,
"BCPAP cell":1,
"DNA damage response":1,
"Punicalagin":1,
"lymph node":2,
"spectral CT":1,
"anaplastic":1,
"lymphoma":1,
"TERT promoter mutation":1,
"BRAFV600E mutation":1,
"GPR48/LGR4":1,
"RSPO2":1,
"β-catenin pathway":1,
"lateral":1,
"papillary":1,
"Acute paraparesis":1,
"Bone metastasis":1,
"Case report":1,
"Euthyroid sick syndrome":1,
"children":1,
"interleukin 6":1,
"interleukin 8":1,
"tumor necrosis factor alpha":1,
"Hodgkin's lymphoma":1,
"extra-nodal":1,
"risk factor":1,
"Cell of origin":1,
"Central nervous system prophylaxis":1,
"Diffuse large B cell lymphoma":1,
"Extranodal lymphoma":1,
"MYD88":1,
"Radiation therapy":1,
"NGS":1,
"cancer relapse":1,
"ctDNA":1,
"synchronous cancer":1,
"kidney disease":1,
"onconephrology":1,
"gestational diabetes":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"LAT1":1,
"heteromeric amino acid transporter (HAT)":1,
"inhibitor":1,
"structure":1,
"transporter":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年11月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
